We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
Douglas Elliman
DOUG
$151M
| $1.3M | ﹤0.01% |
733,575
+321,433
| +78% | +$576K |
2026 Q1
1 quarter
|
|
2052
OP Bancorp
OPBK
$223M
| $1.3M | ﹤0.01% |
86,533
-36,000
| -29% | -$512K |
2025 Q1
5 quarters
|
|
2053
First Watch Restaurant Group
FWRG
$674M
| $1.3M | ﹤0.01% |
100,623
+85,225
| +553% | +$1000K |
2024 Q3
7 quarters
|
|
2054
ResMed
RMD
$35.6B
| $1.29M | ﹤0.01% |
6,635
-374,661
| -98% | -$77.7M |
2026 Q1
1 quarter
|
|
2055
First United
FUNC
$298M
| $1.29M | ﹤0.01% |
29,242
+622
| +2% | +$24.3K |
2025 Q3
3 quarters
|
|
2056
Xometry
XMTR
$5.21B
| $1.29M | ﹤0.01% |
13,353
-36,069
| -73% | -$2.58M |
2026 Q1
1 quarter
|
|
2057
Mammoth Energy Services
TUSK
$129M
| $1.29M | ﹤0.01% |
+395,583
| New | +$1.16M |
2026 Q2
0 quarters
|
|
2058
HawkEye 360 Inc
HAWK
$1.26B
| $1.28M | ﹤0.01% |
+63,521
| New | +$1.75M |
2026 Q2
0 quarters
|
|
2059
Nano Nuclear Energy
NNE
$656M
| $1.27M | ﹤0.01% |
60,068
+9,068
| +18% | +$223K |
2025 Q4
2 quarters
|
|
2060
Eve Holding
EVEX
$544M
| $1.27M | ﹤0.01% |
504,220
+473,666
| +1,550% | +$1.36M |
2025 Q2
4 quarters
|
|
2061
Workday
WDAY
$50.8B
| $1.26M | ﹤0.01% |
10,302
-336,168
| -97% | -$42.6M |
2023 Q4
10 quarters
|
|
2062
Federated Hermes
FHI
$4.28B
| $1.26M | ﹤0.01% |
22,838
+6,985
| +44% | +$395K |
2025 Q2
4 quarters
|
|
2063
Progress Software
PRGS
$1.9B
| $1.26M | ﹤0.01% |
37,517
+11,116
| +42% | +$329K |
2025 Q2
4 quarters
|
|
2064
Jerash Holdings
JRSH
$77.3M
| $1.26M | ﹤0.01% |
+261,731
| New | +$926K |
2026 Q2
0 quarters
|
|
2065
GH Research
GHRS
$1.31B
| $1.26M | ﹤0.01% |
46,697
-44,411
| -49% | -$927K |
2025 Q3
3 quarters
|
|
2066
Karyopharm Therapeutics
KPTI
$10.3M
| $1.25M | ﹤0.01% |
128,451
| – | – |
2022 Q2
16 quarters
|
|
2067
MaxCyte
MXCT
$150M
| $1.25M | ﹤0.01% |
1,014,778
+915,866
| +926% | +$913K |
2026 Q1
1 quarter
|
|
2068
National Healthcare Properties, Inc. Common Stock
NHP
$1.14B
| $1.24M | ﹤0.01% |
+84,910
| New | +$1.19M |
2026 Q2
0 quarters
|
|
2069
Starz Entertainment Corp
STRZ
$360M
| $1.24M | ﹤0.01% |
42,960
-57,360
| -57% | -$1.25M |
2025 Q2
4 quarters
|
|
2070
Crane Co
CR
$10.8B
| $1.24M | ﹤0.01% |
5,549
-68,639
| -93% | -$12.9M |
2026 Q1
1 quarter
|
|
2071
Ocular Therapeutix
OCUL
$1.44B
| $1.24M | ﹤0.01% |
126,033
-614,770
| -83% | -$5.57M |
2025 Q3
3 quarters
|
|
2072
Eastern Company
EML
$146M
| $1.24M | ﹤0.01% |
+44,356
| New | +$974K |
2026 Q2
0 quarters
|
|
2073
Trip.com Group
TCOM
$25.2B
| $1.23M | ﹤0.01% |
30,773
-1,502,391
| -98% | -$74.5M |
2022 Q2
16 quarters
|
|
2074
Daily Journal
DJCO
$835M
| $1.22M | ﹤0.01% |
2,033
-2,199
| -52% | -$1.14M |
2026 Q1
1 quarter
|
|
2075
Investar Holding Corp
ISTR
$385M
| $1.22M | ﹤0.01% |
+40,686
| New | +$1.16M |
2026 Q2
0 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.